Seminars in Liver Disease,
Год журнала:
2023,
Номер
43(03), С. 351 - 366
Опубликована: Авг. 1, 2023
The
COVID-19
pandemic
has
resulted
in
significant
worldwide
morbidity
and
mortality.
In
this
review,
we
examine
the
intricate
relationships
between
liver
diseases.
While
respiratory
manifestations
of
are
well
known,
its
impact
consequences
patients
with
diseases
remain
an
area
ongoing
investigation.
can
induce
injury
through
various
mechanisms
is
associated
higher
mortality
individuals
preexisting
chronic
disease.
Mortality
increases
severity
disease
level
care
required.
outcomes
autoimmune
hepatitis
unclear,
whereas
transplant
recipients
more
likely
to
experience
symptomatic
but
have
comparable
general
population.
Despite
suboptimal
immunological
response,
vaccinations
safe
effective
disease,
although
cases
hepatitis-like
syndrome
been
reported.
conclusion,
implications
diseases;
early
recognition
treatments
important
for
improving
patient
outcomes.
Gut,
Год журнала:
2023,
Номер
72(9), С. 1783 - 1794
Опубликована: Июнь 14, 2023
SARS-CoV-2
infection
may
affect
the
liver
in
healthy
individuals
but
also
influences
course
of
COVID-19
patients
with
chronic
disease
(CLD).
As
described
individuals,
a
strong
SARS-CoV-2-specific
adaptive
immune
response
is
important
for
outcome
COVID-19,
however,
knowledge
on
CLD
limited.Here,
we
review
clinical
and
immunological
features
CLD.
Acute
injury
occurs
many
cases
be
induced
by
multiple
factors,
such
as
cytokines,
direct
viral
or
toxic
effects
drugs.
In
CLD,
have
more
severe
promote
decompensation
particularly
cirrhosis.
Compared
responses
impaired
after
both,
natural
vaccination
improves
at
least
partially
booster
vaccination.Following
vaccination,
rare
acute
vaccine-induced
development
autoimmune-like
hepatitis
been
reported.
However,
concomitant
elevation
enzymes
reversible
under
steroid
treatment.
Vaccines,
Год журнала:
2022,
Номер
10(12), С. 2094 - 2094
Опубликована: Дек. 7, 2022
Children
with
chronic
medical
conditions
are
more
susceptible
to
developing
a
serious
negative
outcome
from
corona
virus
disease
2019
(COVID-19)
than
healthy
children.
This
study
investigated
the
extent
of
COVID-19
vaccine
hesitancy
(VH)
and
its
predictors
in
parents
children
liver
(CLD)
Egypt.
Methods:
A
cross-sectional
was
conducted
at
National
Liver
Institute
September
October
2022,
using
random
sampling
method.
Data
were
collected
validated
Arabic
version
parents’
attitudes
about
childhood
vaccines
(PACV)
scale.
Structural
equation
modeling
(SEM)
discriminant
analysis
used
identify
direct
indirect
determinants
VH.
Results:
Of
173
participating
parents,
81.5%
hesitated
vaccinate
their
child.
Relevant
characteristics
for
included
being
mother
child
(88.2%),
younger
40
years
(92.9%),
illiterate
(92%),
unemployed
(88.8%),
without
health
insurance
(87.8%),
unvaccinated
against
(97.2%),
refused
complete
vaccinations
(85.7%),
not
having
(85.7%)
(p
<
0.05).
Previous
infection
motivated
vaccination
0.0001).
Median
total
PACV,
attitude,
trust
scores
significantly
higher
hesitant
group
vaccinated
=
0.023).
SEM
suggests
that
age
family
size
have
effect,
while
education
level,
income
effects
on
hesitancy.
The
model
showed
acceptable
goodness
fit
(GFI
0.994,
CFI
1,
RMSEA
92.9%
corrected
classification
discriminator
VH
variables
determined
(safety
efficacy,
attitude
trust,
age,
size).
Conclusions:
Many
socioeconomic
factors
affect
toward
child’s
vaccination.
Thus,
increasing
awareness
importance
vaccination,
especially
among
this
risky
group,
may
enhance
decision-making
ability
regarding
vaccinating
BMC Infectious Diseases,
Год журнала:
2025,
Номер
25(1)
Опубликована: Янв. 15, 2025
Cirrhosis
has
been
pointed
out
as
a
clinical
entity
that
leads
to
worse
prognosis
in
COVID-19
patients.
However,
this
concept
is
controversial
the
literature.
We
aimed
evaluate
outcomes
by
comparing
patients
with
cirrhosis
those
without
Brazilian
cohort.
Data
from
20,164
inpatients
were
collected
41
hospitals
Brazil
between
March
September
2020
and
2021
August
2022.
compared
117
632
matched
controls.
A
propensity
score
model
was
used
adjust
for
potential
confounding
variables,
incorporating
some
predictors:
age,
sex
at
birth,
number
of
comorbidities,
hospital
admission,
whether
it
an
in-hospital
manifestation
COVID-19,
admission
year.
Closeness
defined
being
within
0.16
standard
deviations
logit
score.
The
median
age
61
(IQR
50–70)
years
old,
63.4%
men.
There
no
significant
differences
self-reported
symptoms.
Patients
had
lower
hemoglobin
levels
(10.8
vs.
13.1
g/dl),
platelets
(127,000
200,000
cells/mm3),
leukocyte
counts,
well
C-reactive
protein
(63.0
76.0
p
=
0.044)
when
They
also
higher
mortality
controls
(51.3%
21.7%,
<
0.001).
frequencies
intensive
care
unit
38.0%,
0.007),
invasive
mechanical
ventilation
(43.9%
26.6%,
0.001),
dialysis
(17.9%
11.1%,
0.038),
septic
shock
(23.9%
14.9%;
0.015)
institution
palliative
(19.7%
7.4%;
This
study
shown
significantly
incidence
severe
outcomes,
frequency
Our
findings
underscore
need
these
receive
particular
attention
healthcare
teams
allocated
resources.
Public
perception
of
vaccines
reflects
a
complex
interplay
historic
progress,
evolving
societal
values,
and
persistent
challenges
in
public
health
communication.
While
widespread
immunization
remains
one
modern
medicine’s
crowning
achievements,
attitudes
toward
are
shaped
by
legacy
scientific
advancements,
institutional
trust
dynamics,
cultural
narratives.
Despite
enduring
support
for
childhood
immunizations
as
imperative,
evidenced
broad
consensus
on
school
vaccination
requirements,
shifts
confidence
among
certain
groups
highlight
vulnerabilities
understanding.
Lingering
misconceptions
about
vaccine
safety,
amplified
fragmented
information
ecosystems,
coexist
with
majority
belief
their
life-saving
benefits.
The
tension
between
individual
autonomy
collective
responsibility
continue
to
shape
attitudes,
underscoring
the
delicate
balance
forces
that
challenge
it.
At
its
core,
discourse
reveals
paradox:
even
remain
cornerstone
disease
prevention,
perceived
value
is
increasingly
contested
ways
mirror
broader
debates
expertise,
equity,
accountability.
Public
perception
of
vaccines
reflects
a
complex
interplay
historic
progress,
evolving
societal
values,
and
persistent
challenges
in
public
health
communication.
While
widespread
immunization
remains
one
modern
medicine’s
crowning
achievements,
attitudes
toward
are
shaped
by
legacy
scientific
advancements,
institutional
trust
dynamics,
cultural
narratives.
Despite
enduring
support
for
childhood
immunizations
as
imperative,
evidenced
broad
consensus
on
school
vaccination
requirements,
shifts
confidence
among
certain
groups
highlight
vulnerabilities
understanding.
Lingering
misconceptions
about
vaccine
safety,
amplified
fragmented
information
ecosystems,
coexist
with
majority
belief
their
life-saving
benefits.
The
tension
between
individual
autonomy
collective
responsibility
continue
to
shape
attitudes,
underscoring
the
delicate
balance
forces
that
challenge
it.
At
its
core,
discourse
reveals
paradox:
even
remain
cornerstone
disease
prevention,
perceived
value
is
increasingly
contested
ways
mirror
broader
debates
expertise,
equity,
accountability.
World Journal of Gastroenterology,
Год журнала:
2023,
Номер
29(5), С. 800 - 814
Опубликована: Фев. 2, 2023
Since
the
first
identification
in
December
of
2019
and
fast
spread
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection,
it
has
represented
a
dramatic
global
public
health
concern.
Though
affecting
mainly
system,
SARS-CoV-2
disease,
defined
as
disease
(COVID-19),
may
have
systemic
involvement
leading
to
multiple
organ
dysfunction.
Experimental
evidence
about
tropism
for
liver
increasing
hepatic
cytolysis
enzymes
during
infection
support
presence
pathophysiological
relationship
between
SARS-CoV-2.
On
other
side,
patients
with
chronic
been
demonstrated
poor
prognosis
COVID-19.
In
particular,
cirrhosis
appear
extremely
vulnerable
infection.
Moreover,
etiology
vaccination
status
could
affect
COVID-19
outcomes.
This
review
analyzes
impact
stage
related
causes
on
morbidity
mortality,
clinical
outcomes
well
efficacy
disease.
Background
and
Aims:
Diagnosis
code
classification
is
a
common
method
for
cohort
identification
in
cirrhosis
research,
but
it
often
inaccurate
augmented
by
labor-intensive
chart
review.
Natural
language
processing
using
large
models
(LLMs)
potentially
more
accurate
method.
To
assess
LLMs’
potential
identification,
we
compared
code-based
versus
LLM-based
with
review
as
“gold
standard.”
Approach
Results:
We
extracted
conducted
limited
of
3788
discharge
summaries
admissions.
engineered
zero-shot
prompts
Generative
Pre-trained
Transformer
4
to
determine
whether
its
complications
were
active
hospitalization
problems.
calculated
positive
predictive
values
(PPVs)
PPVs
“silver
standard”
all
summaries.
Compared
gold
standard
review,
achieved
82.2%
identifying
cirrhosis,
41.7%
HE,
72.8%
ascites,
59.8%
gastrointestinal
bleeding,
48.8%
spontaneous
bacterial
peritonitis.
the
87.8%–98.8%
accuracies
complications.
Using
LLM
silver
standard,
79.8%
53.9%
55.3%
67.6%
65.5%
Conclusions:
was
highly
manual
This
allowed
us
performance
at
scale
LLMs
standard.
These
results
suggest
could
augment
or
replace
raise
questions
regarding
necessity
Baylor University Medical Center Proceedings,
Год журнала:
2023,
Номер
36(2), С. 151 - 156
Опубликована: Янв. 17, 2023
SARS-CoV-2
vaccinations
were
found
to
be
highly
effective
in
phase
3
clinical
trials.
However,
these
trials
have
not
reported
data
regarding
the
subgroup
of
liver
disease
or
excluded
patients
with
disease.
The
effectiveness
COVID-19
vaccines
among
cirrhosis
(LC)
is
unclear.
We
conducted
this
meta-analysis
assess
vaccination
LC
patients.
A
comprehensive
literature
search
was
include
all
relevant
studies
that
compared
outcomes
who
received
vs.
unvaccinated
Pooled
risk
ratios
(RRs)
95%
confidence
intervals
(CIs)
calculated
by
Mantel-Haenszel
method
within
a
random-effect
model.
Four
51,834
(20,689
at
least
one
dose
vs
31,145
unvaccinated)
included.
COVID-19–related
complications,
including
hospitalization
(RR
0.73,
CI
0.59–0.91,
P
=
0.004),
mortality
0.29,
0.16–0.55,
0.0001),
and
need
for
invasive
mechanical
ventilation
0.11–0.77,
0.01),
significantly
lower
vaccinated
group
group.
reduced
mortality,
intubation,
hospitalization.
LC.
Further
prospective
studies,
preferably
randomized
controlled
trials,
are
necessary
validate
our
findings
determine
which
vaccine
superior
Current Opinion in Gastroenterology,
Год журнала:
2024,
Номер
40(3), С. 119 - 125
Опубликована: Фев. 14, 2024
Purpose
of
review
The
rapid
rollout
and
uptake
novel
coronavirus
disease
2019
(COVID-19)
vaccines
has
been
accompanied
by
a
small
yet
noticeable
accumulation
reports
liver
injury
occurring
after
vaccination.
This
describes
the
present
evidence
surrounding
COVID-19
vaccine-induced
(VILI).
Recent
findings
Liver
vaccine
often
presents
clinically
similar
to
autoimmune
hepatitis,
with
positive
autoantibodies
portal
lobular
inflammatory
infiltrate
varying
degrees
necrosis
on
biopsy.
overwhelming
majority
patients
recover,
spontaneously
or
limited
course
immunosuppression.
overall
incidence
this
phenomenon
appears
be
exceedingly
low.
Summary
Providers
should
remain
vigilant
for
ongoing
VILI
feel
reassured
low
high
likelihood
recovery.
Ongoing
genetic
histological
study,
as
well
longer-term
follow-up
presently
identified
cases,
will
shed
further
light
clinical
entity
VILI.